Princy N. Kumar, MD

Chief, Division of Infectious Diseases
Georgetown University Medical Center

Disclosure(s): American Gene Technologies: Grant/Research Support; BioHaven: Grant/Research Support; Eli Lilly: Grant/Research Support; Gilead: Advisor/Consultant, Grant/Research Support, Stocks/Bonds; GSK: Grant/Research Support, Stocks/Bonds; Johnson&Johnson: Advisor/Consultant, Stocks/Bonds; Merck: Advisor/Consultant, Grant/Research Support, Stocks/Bonds; Moderna: Stocks/Bonds; Pfizer: Stocks/Bonds; Regeneron: Grant/Research Support; TheraTechnologies: Grant/Research Support; ViiV: Advisor/Consultant

Poster(s):

• 200 - The Utility of a Rapid Multiplex PCR Assay in the Management of Staphylococcus Aureus Bacteremia at a Tertiary Care Center
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET